---
title: "Asymchem Clarifies Size of H-Share Restricted Share Grant"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292120742.md"
description: "Asymchem Laboratories (HK:6821) clarified that it granted 640,000 H-share incentive shares to employees on July 8, 2026, correcting a prior disclosure. All other details in the previous announcement remain unchanged. The company maintains a 'Hold' rating with a HK$120 price target."
datetime: "2026-07-08T22:37:14.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292120742.md)
  - [en](https://longbridge.com/en/news/292120742.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292120742.md)
generator: "portal-rs"
---

# Asymchem Clarifies Size of H-Share Restricted Share Grant

Asymchem Laboratories (Tianjin) Co., Ltd. Class H ( (HK:6821) ) just unveiled an announcement.

Asymchem Laboratories (Tianjin) Co., Ltd., a Hong Kong-listed Chinese pharmaceutical services company, is overseen by a board chaired by CEO Dr. Hao Hong and composed of executive, non-executive and independent non-executive directors. The company focuses on laboratory-based support for drug development across global markets.

The company issued a clarification stating that, under its H Share Restricted Share Scheme, it granted an aggregate of 640,000 H share incentive shares to certain employee participants on 8 July 2026. Apart from this correction to the disclosed grant size, all other information in the prior announcement remains unchanged, signaling a targeted move to refine disclosures while maintaining the substance of its employee incentive program.

The most recent analyst rating on (HK:6821) stock is a Hold  
 with a HK$120.00 price target.  
 To see the full list of analyst forecasts on Asymchem Laboratories (Tianjin) Co., Ltd. Class H stock,  
 see the HK:6821 Stock Forecast page. 

**More about Asymchem Laboratories (Tianjin) Co., Ltd. Class H**

Asymchem Laboratories (Tianjin) Co., Ltd. is a joint stock company incorporated in the People’s Republic of China with its H shares listed on the Stock Exchange of Hong Kong under stock code 6821. The company operates in the pharmaceutical and biotechnology services sector, providing laboratory-based research and development support, and its governance structure includes a mix of executive, non-executive and independent non-executive directors, led by chairperson and CEO Dr. Hao Hong.

**Average Trading Volume:** 658,510

**Technical Sentiment Signal:** Buy

**Current Market Cap:** HK$65.31B

For a thorough assessment of 6821 stock, go to TipRanks’ Stock Analysis page.

### Related Stocks

- [002821.CN](https://longbridge.com/en/quote/002821.CN.md)
- [06821.HK](https://longbridge.com/en/quote/06821.HK.md)

## Related News & Research

- [Asymchem Proposes 2026 A Share Incentive Scheme for Key Staff](https://longbridge.com/en/news/292092019.md)
- [Asymchem Expands H Share Incentive Grants Without Diluting Shareholders](https://longbridge.com/en/news/292086113.md)
- [Sihuan Pharma grants 116,150,000 share awards under 2026 incentive scheme at HK$ 0.74 each](https://longbridge.com/en/news/297656388.md)
- [Asymchem Laboratories announces extraordinary general meeting](https://longbridge.com/en/news/294528537.md)
- [Asymchem Aligns H Share Register Closure for Dividend and Shareholder Meetings](https://longbridge.com/en/news/290807877.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**